Marker evaluation pipeline: cases and controls.

a)Overlapping specimens in the Mini-Triage and Triage sets b)Healthy Controls: women enrolled in prospective screening trials who remained free of ovarian cancer for at least two years after serum collection. c)Surgical Benigns: women with surgically confirmed benign ovarian pathology. d)Surgical Normals: women that underwent surgery but no ovarian pathology was identified.